NCT06815146

Brief Summary

Erector Spinae Area (ESP) Block and Mid-Transverse Process to Pleura Block(MTP) have recently been described for the treatment of pain after lumbar spinal surgery. Although these blocks have been shown to be effective in the treatment of pain after lumbar spinal surgery when compared with postoperative pain, they have not been compared in terms of the quality of recovery and opioid consumption after lumbar spinal surgery. The aim of this clinical trial is to compare the effects of Erector Spinae Area (ESP) Block and Mid-Transverse Process to Pleura Block(MTP) on quality of recovery and opioid consumption in patients scheduled for lumbar spinal surgery. The effects of the 2 blocks on postoperative pain will also be compared and recorded.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
126

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 27, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

February 7, 2025

Completed
8 days until next milestone

Study Start

First participant enrolled

February 15, 2025

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 15, 2026

Completed
Last Updated

February 7, 2025

Status Verified

February 1, 2025

Enrollment Period

1 year

First QC Date

January 27, 2025

Last Update Submit

February 3, 2025

Conditions

Keywords

opioid consumptionquality of recovery

Outcome Measures

Primary Outcomes (1)

  • postoperative opioid consumption

    The patient will be administered tramadol PCA every eight hours and recorded.

    PCA results will be recorded at the 1st, 6th, 12th, 24th hours postoperatively.

Secondary Outcomes (1)

  • quality of recovery

    24 hours

Study Arms (2)

esp block

ACTIVE COMPARATOR
Diagnostic Test: Numeretic rating scale (NRS)Diagnostic Test: Quality of Results (QoR-40)Other: Opioid consuption

mtp block

EXPERIMENTAL
Diagnostic Test: Numeretic rating scale (NRS)Diagnostic Test: Quality of Results (QoR-40)Other: Opioid consuption

Interventions

NRS is a pain intensity determination system based on the person being asked to describe their pain on a scale of 0 (none), 10 (unbearable pain) and a point between.

esp blockmtp block

Several rating scales have been developed to measure quality of recovery after surgery and anaesthesia, but the most extensively used is the QoR-40, a 40-item questionnaire that provides a global score and subscores across five dimensions: patient support, comfort, emotions, physical independence, and pain.

esp blockmtp block

Opioid consuption will be recorded from PCA

esp blockmtp block

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Elective Lumbar Spinal surgery performed
  • ASA I-III
  • years old

You may not qualify if:

  • Refusal at enrollment
  • Request for withdrawal from the study
  • Inability to give informed consent
  • Emergency surgery
  • Bleeding diathesis
  • Presence of contraindications to the LA agents used in this study
  • Use of chronic opioids
  • Psychiatric disorders
  • Presence of infection at the injection site

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Eskin MB, Ceylan A, Ozhan MO, Atik B. Ultrasound-guided erector spinae block versus mid-transverse process to pleura block for postoperative analgesia in lumbar spinal surgery. Anaesthesist. 2020 Oct;69(10):742-750. doi: 10.1007/s00101-020-00848-w. Epub 2020 Sep 21.

    PMID: 32955601BACKGROUND

Central Study Contacts

Sinem Sarı, Prof Dr

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Masking Details
Blind patients and postoperative follow-ups will not know which group the patient is in the study. Randomization will be done with computer support.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, Prof

Study Record Dates

First Submitted

January 27, 2025

First Posted

February 7, 2025

Study Start

February 15, 2025

Primary Completion

February 15, 2026

Study Completion

February 15, 2026

Last Updated

February 7, 2025

Record last verified: 2025-02